(Circulation. 1999;100:e109.)
© 1999 American Heart Association, Inc.
Circulation Electronic Pages |
Lenox Hill Hospital, New York, NY
| Introduction |
|---|
|
|
|---|
The data presented by Losordo and colleagues1 concerning direct myocardial gene transfer of vascular endothelial growth factor (VEGF) have significant clinical implications and add further support to the concept of using growth factors to stimulate neovascularization in patients with ischemic heart disease. The question that emerges at this stage of progress is whether we should be concerned about the possibility that these growth factors may accelerate the progression of atherosclerosis. This concern is based on the following:
1. In the absence of atherosclerosis, adult coronary arteries are normally devoid of a microvasculature except for a scant plexus of vasa vasorum in the adventitia and outer media.2
2. The formation of new microvessels in human atherosclerotic plaque is associated with high cellular proliferative activity in the plaque.3
3. The endothelial cells of intraplaque microvessels in advanced atherosclerotic lesions have a high level of VEGF expression. Furthermore, more intense VEGF expression was noted in totally occlusive lesions with extensive neovascularization.4
4. The relationship between vascular growth factors and atherosclerosis progression or neointimal hyperplasia does not appear to be unique to VEGF. A recent study suggest that bFGF (basic fibroblast growth factor) may incite aggressive vascular neointimal proliferation in ovariectomized female sheep.5
To investigate this possibility, planned clinical trials should include a quantitative assessment of atherosclerotic plaque volume by intravascular ultrasound to monitor the degree of progression of atherosclerosis, and the sample size of these trials should be sufficient to statistically establish that the growth factor tested does not increase the incidence of myocardial infarction and cardiac death.
| References |
|---|
|
|
|---|
2. Barger AC, Beeuwkes R III, Lainey LL, Silverman KJ. Hypothesis: vasa vasorum and neovascularization of human coronary arteries: a possible role in the pathophysiology of atherosclerosis. N Engl J Med. 1984;310:175177.[Medline] [Order article via Infotrieve]
3. OBrien ER, Garvin MR, Dev R, Stewart DK, Hinohara T, Simpson JB, Schwartz SM. Angiogenesis in human coronary atherosclerotic plaques. Am J Pathol. 1994;145:883894.[Abstract]
4.
Inoue M, Itoh H, Ueda M, Naruko T, Kojima A, Komatsu
R, Doi K, Ogawa Y, Tamura N, Takaya K, Igaki T, Yamashita J, Chun TH,
Masatsugu K, Becker AE, Nakao K. Vascular endothelial
growth factor (VEGF) expression in human coronary
atherosclerotic lesions: possible
pathophysiological significance of VEGF in
progression of atherosclerosis. Circulation. 1998;98:21082116.
5.
Selzman CH, Gaynor JS, Turner AS, Johnson SM, Horwitz
LD, Whitehill TA, Harken AH. Ovarian ablation alone promotes
aortic intimal hyperplasia and accumulation of fibroblast growth
factor. Circulation. 1998;98:20492054.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |